IL85957A - Living stromal tissue prepared in vitro comprising stromal cells and connective tissue proteins - Google Patents
Living stromal tissue prepared in vitro comprising stromal cells and connective tissue proteinsInfo
- Publication number
- IL85957A IL85957A IL8595788A IL8595788A IL85957A IL 85957 A IL85957 A IL 85957A IL 8595788 A IL8595788 A IL 8595788A IL 8595788 A IL8595788 A IL 8595788A IL 85957 A IL85957 A IL 85957A
- Authority
- IL
- Israel
- Prior art keywords
- cells
- stromal
- framework
- living
- testing
- Prior art date
Links
- 210000002536 stromal cell Anatomy 0.000 title claims description 76
- 210000001519 tissue Anatomy 0.000 title claims description 40
- 238000000338 in vitro Methods 0.000 title claims description 30
- 102000004169 proteins and genes Human genes 0.000 title claims description 17
- 108090000623 proteins and genes Proteins 0.000 title claims description 17
- 210000002808 connective tissue Anatomy 0.000 title claims description 16
- 238000000034 method Methods 0.000 claims description 95
- 238000012360 testing method Methods 0.000 claims description 81
- 210000004027 cell Anatomy 0.000 claims description 74
- 210000001185 bone marrow Anatomy 0.000 claims description 50
- 239000000463 material Substances 0.000 claims description 44
- 210000002950 fibroblast Anatomy 0.000 claims description 40
- 238000004113 cell culture Methods 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 29
- 230000012010 growth Effects 0.000 claims description 27
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 26
- 230000000694 effects Effects 0.000 claims description 22
- 210000002798 bone marrow cell Anatomy 0.000 claims description 17
- 102000008186 Collagen Human genes 0.000 claims description 15
- 108010035532 Collagen Proteins 0.000 claims description 15
- 229920001436 collagen Polymers 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 15
- 210000002540 macrophage Anatomy 0.000 claims description 15
- 206010028980 Neoplasm Diseases 0.000 claims description 14
- 201000011510 cancer Diseases 0.000 claims description 13
- 210000001789 adipocyte Anatomy 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 9
- 210000002889 endothelial cell Anatomy 0.000 claims description 9
- 210000002510 keratinocyte Anatomy 0.000 claims description 9
- 210000002752 melanocyte Anatomy 0.000 claims description 9
- 210000001616 monocyte Anatomy 0.000 claims description 8
- 230000003013 cytotoxicity Effects 0.000 claims description 7
- 231100000135 cytotoxicity Toxicity 0.000 claims description 7
- 230000001413 cellular effect Effects 0.000 claims description 6
- 210000004185 liver Anatomy 0.000 claims description 5
- 210000003491 skin Anatomy 0.000 claims description 4
- 210000004927 skin cell Anatomy 0.000 claims description 3
- 230000003211 malignant effect Effects 0.000 claims description 2
- 230000002503 metabolic effect Effects 0.000 claims description 2
- 210000004738 parenchymal cell Anatomy 0.000 claims 23
- -1 polypropylene Polymers 0.000 claims 21
- 230000002380 cytological effect Effects 0.000 claims 19
- 229940079593 drug Drugs 0.000 claims 13
- 230000036210 malignancy Effects 0.000 claims 11
- 238000012544 monitoring process Methods 0.000 claims 11
- 210000003630 histaminocyte Anatomy 0.000 claims 8
- 229920000742 Cotton Polymers 0.000 claims 7
- 229920002307 Dextran Polymers 0.000 claims 7
- 108010010803 Gelatin Proteins 0.000 claims 7
- 239000000020 Nitrocellulose Substances 0.000 claims 7
- 239000004952 Polyamide Substances 0.000 claims 7
- 229920000954 Polyglycolide Polymers 0.000 claims 7
- 239000004743 Polypropylene Substances 0.000 claims 7
- 239000004793 Polystyrene Substances 0.000 claims 7
- 239000002729 catgut Substances 0.000 claims 7
- 229920002678 cellulose Polymers 0.000 claims 7
- 239000001913 cellulose Substances 0.000 claims 7
- 229920000159 gelatin Polymers 0.000 claims 7
- 239000008273 gelatin Substances 0.000 claims 7
- 235000019322 gelatine Nutrition 0.000 claims 7
- 235000011852 gelatine desserts Nutrition 0.000 claims 7
- 210000003494 hepatocyte Anatomy 0.000 claims 7
- 229920001220 nitrocellulos Polymers 0.000 claims 7
- 235000015097 nutrients Nutrition 0.000 claims 7
- 210000003668 pericyte Anatomy 0.000 claims 7
- 210000004180 plasmocyte Anatomy 0.000 claims 7
- 229920000058 polyacrylate Polymers 0.000 claims 7
- 229920002647 polyamide Polymers 0.000 claims 7
- 229920000515 polycarbonate Polymers 0.000 claims 7
- 239000004417 polycarbonate Substances 0.000 claims 7
- 239000004633 polyglycolic acid Substances 0.000 claims 7
- 229920001155 polypropylene Polymers 0.000 claims 7
- 229920002223 polystyrene Polymers 0.000 claims 7
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 7
- 229920002554 vinyl polymer Polymers 0.000 claims 7
- 210000000265 leukocyte Anatomy 0.000 claims 6
- 229920000728 polyester Polymers 0.000 claims 6
- 210000005229 liver cell Anatomy 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002009 allergenic effect Effects 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 230000002227 vasoactive effect Effects 0.000 claims 2
- 238000002513 implantation Methods 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000008569 process Effects 0.000 description 15
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 230000002708 enhancing effect Effects 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 10
- 230000010076 replication Effects 0.000 description 10
- 239000010410 layer Substances 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 230000001464 adherent effect Effects 0.000 description 7
- 230000008014 freezing Effects 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 5
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 5
- 238000010322 bone marrow transplantation Methods 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000003394 haemopoietic effect Effects 0.000 description 5
- 230000003248 secreting effect Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 210000005087 mononuclear cell Anatomy 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 3
- 108010059712 Pronase Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012080 ambient air Substances 0.000 description 3
- 239000003855 balanced salt solution Substances 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- VWQWXZAWFPZJDA-CGVGKPPMSA-N hydrocortisone succinate Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COC(=O)CCC(O)=O)[C@@H]4[C@@H]3CCC2=C1 VWQWXZAWFPZJDA-CGVGKPPMSA-N 0.000 description 3
- 229950006240 hydrocortisone succinate Drugs 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002577 cryoprotective agent Substances 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000001865 kupffer cell Anatomy 0.000 description 2
- 210000003593 megakaryocyte Anatomy 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004976 peripheral blood cell Anatomy 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000002629 repopulating effect Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 206010048396 Bone marrow transplant rejection Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 102100033167 Elastin Human genes 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 206010060872 Transplant failure Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000002338 cryopreservative effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000000925 erythroid effect Effects 0.000 description 1
- 230000000913 erythropoietic effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000000788 granulopoietic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 210000001357 hemopoietic progenitor cell Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000002979 macrophagic effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 230000008722 morphological abnormality Effects 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/036,154 US4721096A (en) | 1986-04-18 | 1987-04-03 | Process for replicating bone marrow in vitro and using the same |
| US3811087A | 1987-04-14 | 1987-04-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL85957A0 IL85957A0 (en) | 1988-09-30 |
| IL85957A true IL85957A (en) | 1994-06-24 |
Family
ID=26712881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL8595788A IL85957A (en) | 1987-04-03 | 1988-04-01 | Living stromal tissue prepared in vitro comprising stromal cells and connective tissue proteins |
Country Status (4)
| Country | Link |
|---|---|
| ES (1) | ES2009894A6 (pt) |
| GR (1) | GR1003185B (pt) |
| IL (1) | IL85957A (pt) |
| PT (1) | PT87136B (pt) |
-
1988
- 1988-03-30 PT PT8713688A patent/PT87136B/pt not_active IP Right Cessation
- 1988-04-01 IL IL8595788A patent/IL85957A/en not_active IP Right Cessation
- 1988-04-01 GR GR880100216A patent/GR1003185B/el not_active IP Right Cessation
- 1988-04-04 ES ES8801024A patent/ES2009894A6/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT87136B (pt) | 1992-11-30 |
| PT87136A (pt) | 1988-04-01 |
| IL85957A0 (en) | 1988-09-30 |
| GR1003185B (el) | 1999-09-01 |
| GR880100216A (el) | 1989-01-31 |
| ES2009894A6 (es) | 1989-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0309456B1 (en) | Stromal tissue | |
| CA1335657C (en) | Three-dimensional cell and tissue culture system | |
| US5518915A (en) | Three-Dimensional mucosal cell and tissue culture system | |
| US5160490A (en) | Three-dimensional cell and tissue culture apparatus | |
| US4963489A (en) | Three-dimensional cell and tissue culture system | |
| US4721096A (en) | Process for replicating bone marrow in vitro and using the same | |
| US5478739A (en) | Three-dimensional stromal cell and tissue culture system | |
| AU595813B2 (en) | Process for replicating bone marrow in vitro | |
| CA1310926C (en) | Process for replicating bone marrow and other tissues in vitro and using the same | |
| IL85957A (en) | Living stromal tissue prepared in vitro comprising stromal cells and connective tissue proteins | |
| HK1007684B (en) | Stromal tissue | |
| AU644578B2 (en) | Three-dimensional cell and tissue culture system | |
| KR0156685B1 (ko) | 3차원 배양물을 이용한 약물의 효과를 테스트하는 방법 | |
| KR0156571B1 (ko) | 3차원 세포 및 조직 배양계 | |
| IL91536A (en) | Three-dimensional cell and tissue culture system comprising parenchymal cells cultured on a living stromal tissue methods for preparing said culturing system and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| RH | Patent void | ||
| MM9K | Patent not in force due to non-payment of renewal fees |